Pellino-1 (PELI1), a novel cancer-related E3 ubiquitin ligase, has been found to be upregulated and correlated with poor clinical prognosis in a variety of cancers, such as large B cell lymphomas [5, 6], lung cancer [7, 8] and breast cancer [9]. This evidence concerns the gene PELI1 and breast cancer.